(Q30357081)

English

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 June 2017

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. (English)

1 reference

Europe PubMed Central

20 June 2017

0 references

influenza A virus

object named as

influenza A virus

1 reference

based on heuristic

inferred from title

6

object named as

Osterhaus AD

1 reference

Europe PubMed Central

20 June 2017

author name string

Kreijtz JH

1

1 reference

Europe PubMed Central

20 June 2017

Bodewes R

2

1 reference

Europe PubMed Central

20 June 2017

van Amerongen G

3

1 reference

Europe PubMed Central

20 June 2017

Kuiken T

4

1 reference

Europe PubMed Central

20 June 2017

Fouchier RA

5

1 reference

Europe PubMed Central

20 June 2017

Rimmelzwaan GF

7

1 reference

Europe PubMed Central

20 June 2017

language of work or name

0 references

publication date

7 September 2006

1 reference

Europe PubMed Central

20 June 2017

1 reference

Europe PubMed Central

20 June 2017

25

1 reference

Europe PubMed Central

20 June 2017

4

1 reference

Europe PubMed Central

20 June 2017

612-620

1 reference

Europe PubMed Central

20 June 2017

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

A pandemic warning?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Avian influenza A (H5N1) infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Evolution of H5N1 avian influenza viruses in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Gene composition of high-yielding influenza vaccine strains obtained by recombination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

T cell memory in the lung airways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Human disease from influenza A (H5N1), Thailand, 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.08.036

1 reference

Europe PubMed Central

20 June 2017

1 reference

Europe PubMed Central

20 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30357081&oldid=1802635129"